Effects of Sophora alopecuroides var. alopecuroides on the heroin withdrawal symptoms
Phase 3
Recruiting
- Conditions
- Heroin addiction.Opioid dependence with withdrawalF11.23
- Registration Number
- IRCT20090804002288N16
- Lead Sponsor
- Vice Chancellor for Research, Research Institute for Islamic and Complementary Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 100
Inclusion Criteria
Iranian male outpatients who according to the DSM-V criteria are dependent on heroin for at least 1 year
Patients whose urinalysis result for detection of 6-acetylmorphine is positive
Patients aged 18 to 70 years
Patients whose heroin dose has been constant for at least one month before study
Patients residing in addiction treatment camp
Patients who have not used heroin for at least 5 hours before arrival in camp
Exclusion Criteria
Individuals who besides heroin abuse other substances except for tobacco
Patients who have other psychiatric diseases
Individuals who have other important diseases like cardiac, renal and hepatic disease
Individuals who have organic brain disease
Individuals who have mental retardation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Score of clinical opiate withdrawal scale. Timepoint: Before intervention and 3 and 8 days after intervention. Method of measurement: Clinical Opiate Withdrawal Scale.;Patient global impression regarding efficacy of treatment. Timepoint: Eight days after intervention. Method of measurement: Visual analog scale (ten centimeter ruler).
- Secondary Outcome Measures
Name Time Method